Cargando…

Prediagnosis radiological progression in rheumatoid arthritis: a novel tool to study the effects of early DMARD therapy

Detalles Bibliográficos
Autores principales:	Wick, MC, Weiss, RJ, Klareskog, L, van Vollenhoven, RF
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2004
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2833775/ http://dx.doi.org/10.1186/ar1134

Ejemplares similares

Multidrug resistance proteins and DMARD efficacy in rheumatoid arthritis
por: Jansen, G, et al.
Publicado: (2004)

Are DMARDs enough to prevent surgery in rheumatoid hands?
por: Sim, Yeap Swan
Publicado: (2015)

Biopsy-verified response of severe lupus nephritis to rituximab (anti-CD20 monoclonal antibody) plus cyclophosphamide after biopsy-documented failure to respond to NIH-protocol cyclophosphamide
por: van Vollenhoven, RF, et al.
Publicado: (2002)

Low levels of apoptosis and high FLIP expression in early rheumatoid arthritis synovium
por: Ulfgren, A-K, et al.
Publicado: (2002)

Molecular mechanisms of resistance to disease modifying antirheumatic drugs (DMARDs)
por: Jansen, G, et al.
Publicado: (2002)

Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis
por: Mullazehi, Mohammed, et al.
Publicado: (2012)

Increased apoptosis level in late stages of rheumatoid arthritis correlates with macrophage number
por: Catrina, AI, et al.
Publicado: (2001)

Anti-tumour necrosis factor therapy modulates the OPG/OPGL system in rheumatoid arthritis synovium
por: Catrina, AI, et al.
Publicado: (2004)

Synovial Histopathology in Early Rheumatoid Arthritis
por: Hirohata, Shunsei, et al.
Publicado: (2000)

Immunogenetic Aspects of Disease Progression in Rheumatoid Arthritis
por: Wassmuth, Ralf, et al.
Publicado: (2000)

CD28nullCD4(+ )T cells: an effector memory T cell population in patients with rheumatoid arthritis
por: Fasth, AER, et al.
Publicado: (2004)

Therapy with soluble TNF receptor (etanercept) induces apoptosis in rheumatoid arthritis (RA) synovium
por: Catrina, AI, et al.
Publicado: (2003)

Damage progression in rheumatoid arthritis: the role of biologic agents
por: Favalli, Ennio Giulio
Publicado: (2012)

Effects of anti-rheumatic treatments on expression of microsomal prostaglandin E synthase-1 in rheumatoid arthritis synovium
por: Korotkova, M, et al.
Publicado: (2004)

Autoantibodies predict progression to rheumatoid arthritis in undifferentiated arthritis: a prospective cohort study
por: van Gaalen, FA, et al.
Publicado: (2003)

Intestinal anaerobic bacteria in early rheumatoid arthritis (RA)
por: Toivanen, P, et al.
Publicado: (2002)

Altered T Cell Differentiation in Patients with Early Rheumatoid Arthritis
por: Skapenko, Alla, et al.
Publicado: (2000)

Current and Emerging DMARDs for the Treatment of Rheumatoid Arthritis
por: Mysler, Eduardo, et al.
Publicado: (2021)

The diagnostic significance of autoantibodies in patients with very early rheumatoid arthritis
por: Nell, V, et al.
Publicado: (2003)

Comparison of knee joints with small joints: implications for pathogenesis and evaluation of treatment in rheumatoid arthritis
por: Kraan, MC, et al.
Publicado: (2002)

Early DAS response after DMARD-start increases probability of achieving sustained DMARD-free remission in rheumatoid arthritis
por: Verstappen, M., et al.
Publicado: (2020)

Identification of biomarkers in patients with rheumatoid arthritis responsive to DMARDs but with progressive bone erosion
por: Marasco, Emiliano, et al.
Publicado: (2023)

Genetics of Rheumatoid Arthritis
por: Nepom, Gerald T
Publicado: (2000)

Chemokines in Rheumatoid Arthritis
por: Koch, Alisa
Publicado: (2000)

CD25brightCD4(+ )regulatory T cells accumulate in inflamed joints of patients with chronic rheumatic disease
por: Cao, D, et al.
Publicado: (2004)

Early treatment of recent-onset rheumatoid arthritis patients impairs the effect of HLA class II antigents on the progression of joint destruction
por: Lard, LR, et al.
Publicado: (2001)

Treatment of Rheumatoid Arthritis with Biologic DMARDS (Rituximab and Etanercept)
por: Gashi, Afrim A., et al.
Publicado: (2014)

Delayed conventional DMARDs therapy is effective in Rheumatoid Arthritis
por: Ahsan, Tasnim, et al.
Publicado: (2017)

Risk for infections with glucocorticoids and DMARDs in patients with rheumatoid arthritis
por: Riley, Thomas R, et al.
Publicado: (2021)

Autoreactivity patterns in rheumatoid arthritis
por: Behrens, S, et al.
Publicado: (2001)

Etanercept for Treating Rheumatoid Arthritis
por: Moreland, Larry W
Publicado: (2000)

Antineutrophil cytoplasmic antibodies in synovial fluid from patients with early rheumatoid arthritis
por: Puszczewicz, M, et al.
Publicado: (2003)

Ability of second-generation anti-cyclic citrullinated peptide (CCP) to predict rheumatoid arthritis in patients with early arthritis
por: Saraux, A, et al.
Publicado: (2003)

A customized monocyte cDNA microarray for diagnosis of rheumatoid arthritis and prognosis of anti-TNF-α therapy
por: Stuhlmüller, B, et al.
Publicado: (2004)

Autoantibodies to deiminated fibrinogen are the most efficient serological criterion for early rheumatoid arthritis diagnosis
por: Nogueira, L, et al.
Publicado: (2003)

Anti-BIP antibodies in rheumatoid arthritis
por: Panayi, GS, et al.
Publicado: (2003)

Fibrinogen-specific T cells in rheumatoid arthritis
por: Vossenaar, E, et al.
Publicado: (2003)

Dendritic cell subsets in rheumatoid arthritis
por: Summers, K, et al.
Publicado: (2001)

Histopathology of Bone Erosions in Rheumatoid Arthritis
por: Gravallese, Ellen, et al.
Publicado: (2000)

Activation of Synovial Fibroblasts in Rheumatoid Arthritis
por: Gay, Steffen, et al.
Publicado: (2000)

Cannot write session to /tmp/vufind_sessions/sess_cgm51nl2f98grccpkckgcctgv8